G Kolarz

Author PubWeight™ 42.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum 1989 1.48
2 Pemphigus erythematosus-like rash in a patient on penicillamine. Br Med J 1977 1.39
3 CADIAG: approaches to computer-assisted medical diagnosis. Comput Biol Med 1985 1.19
4 Demonstration of antibodies to collagen and of collagen-anticollagen immune complexes in rheumatoid arthritis synovial fluids. Ann Rheum Dis 1975 1.19
5 [Autoimmune phenomena in D-penicillamine therapy]. Acta Med Austriaca 1975 1.17
6 Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis. Rheumatol Int 2005 1.11
7 HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis. J Rheumatol 1984 1.02
8 Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol 2003 1.00
9 Seropositive rheumatoid arthritis associated with decreased diffusion capacity of the lung. Ann Rheum Dis 1976 0.99
10 Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay. Arthritis Rheum 1978 0.99
11 Letter: Serum beta2-microglobulin and SLE. Arthritis Rheum 1976 0.96
12 Lymphocyte transformation to denatured type I collagen and B lymphocyte alloantigens in rheumatoid arthritis. Arthritis Rheum 1980 0.94
13 [High dosage vitamin E therapy in patients with activated arthrosis]. Z Rheumatol 1991 0.87
14 Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop (Belle Mead NJ) 1999 0.85
15 Tomographic examinations of sacroiliac joints in adult patients with rheumatoid arthritis. J Rheumatol 1980 0.84
16 [Leukocytic changes under treatment with L-asparaginase]. Wien Med Wochenschr 1971 0.83
17 Problems in establishing the medical expert systems CADIAG-1 and CADIAG-2 in rheumatology. J Med Syst 1986 0.83
18 Predicting factors for severity of rheumatoid arthritis: a prospective multicenter cohort study of 172 patients over 3 years. Rheumatol Int 2007 0.83
19 Copper in ankylosing spondylitis and rheumatoid arthritis. Scand J Rheumatol 1978 0.82
20 HLA-B8 in caucasian patients with systemic lupus erythematosus. Scand J Rheumatol 1978 0.82
21 Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs. J Rheumatol 1993 0.82
22 [Pulmonary manifestations in connective tissue diseases (author's transl)]. Prax Klin Pneumol 1979 0.81
23 [Radiosynoviorthesis with yttrium-90-silicate. Results compared to aurum-198-colloid and whole body radiation load]. Acta Med Austriaca 1979 0.80
24 Serum osteoprotegerin but not receptor activator of NF-kappaB ligand correlates with Larsen score in rheumatoid arthritis. Ann Rheum Dis 2004 0.79
25 Vitamin E and rheumatoid arthritis. Arthritis Rheum 1991 0.79
26 [Technetium uptake in the parotid gland. Value of functional parameters in Sjögren's syndrome]. Nuklearmedizin 1976 0.79
27 [New approaches to computer-assisted diagnosis of rheumatologic diseases]. Radiologe 1995 0.79
28 [EA rosettes in patients with progressive chronic polyarthritis]. Z Rheumatol 1976 0.78
29 [Possible involvement of the auditory system in rheumatoid arthritis]. Z Rheumatol 1980 0.78
30 [Hereditary hemorrhagic teleangiectasy (Osler's disease). Report on 24 patients, especially on their liver findings]. Munch Med Wochenschr 1969 0.78
31 [Lung changes under busulfan therapy in a case of chronic myelosis]. Zentralbl Allg Pathol 1970 0.78
32 Pertechnetate uptake of joints in rheumatoid arthritis. Eur J Nucl Med 1976 0.78
33 Representation and semiautomatic acquisition of medical knowledge in CADIAG-1 and CADIAG-2. Comput Biomed Res 1986 0.77
34 Development and evaluation of fuzzy criteria for the diagnosis of rheumatoid arthritis. Methods Inf Med 1996 0.76
35 Antibodies to pancreatic duct cells in Sjögren's syndrome and rheumatoid arthritis. Gut 1977 0.76
36 Present state of the medical expert system CADIAG-2. Methods Inf Med 1985 0.76
37 The efficacy and safety of fentiazac and diclofenac sodium in peri-arthritis of the shoulder: a multi-centre, double-blind comparison. J Int Med Res 1988 0.76
38 A method to differentiate between anti-C1q antibodies and C1q-binding immune complexes using collagenase-digested solid phase C1q. J Immunol Methods 1991 0.76
39 A prospective evaluation of the medical consultation system CADIAG-II/RHEUMA in a rheumatological outpatient clinic. Methods Inf Med 2001 0.76
40 Lung involvement in rheumatoid factor-negative arthritis. Scand J Rheumatol 1993 0.75
41 NSAID associated gastritis and Helicobacter pylori. J Rheumatol 1990 0.75
42 Inhibition of cytokine production and adhesion molecule expression by ibuprofen is without effect on transendothelial migration of monocytes. Inflammation 1999 0.75
43 Systemic lupus erythematosus and pulmonary manifestation. Ann Rheum Dis 1980 0.75
44 [Clinical experience with levamisole treatment of patients with systemic lupus erythematosus (author's transl)]. Wien Klin Wochenschr 1979 0.75
45 Letter: Respiratory function in rheumatoid arthritis. Br Med J 1975 0.75
46 Bronchoalveolar lavage in rheumatoid arthritis and secondary Sjögren's syndrome. Lung 1990 0.75
47 Modulation of nitric oxide synthase activity by ibuprofen. Inflammation 1997 0.75
48 [The significance of bone scintigraphy for diagnosis and therapy of osteogenic sarcoma to long bones (author's transl)]. Arch Orthop Unfallchir 1973 0.75
49 [Investigations of the final settling of implanted hip-joints by use of 85Sr (author's transl)]. Z Orthop Ihre Grenzgeb 1977 0.75
50 Prediction of interstitial lung involvement in rheumatoid arthritis. The value of clinical data, chest roentgenogram, lung function, and serologic parameters. Chest 1992 0.75
51 [99m-Tc uptake by the parotid gland in Sjögren's syndrome]. Verh Dtsch Ges Rheumatol 1976 0.75
52 [99m-Tc uptake by the parotid gland in Sjögren's syndrome (proceedings)]. Z Rheumatol 1976 0.75
53 [Binding affinity of ibuprofen in human tissues]. Arzneimittelforschung 1992 0.75
54 [Helicobacter pylori and nonsteroidal antirheumatics]. Dtsch Med Wochenschr 1990 0.75
55 [Acute lymphadenosis with an unusual course]. Wien Z Inn Med 1971 0.75
56 [Measurement of neutral peptidase activity in leukocyte homogenate with carboxypropionylphenylalanine-p-nitranilide substrate]. Wien Med Wochenschr 1973 0.75
57 Double-blind, cross-over, international multicentre investigation of two doses of indoprofen compared with ASA and placebo in rheumatoid arthritis. Eur J Rheumatol Inflamm 1981 0.75
58 Differences in anti-Fab antibodies in adult and late onset rheumatoid arthritis. Rheumatol Int 1993 0.75
59 [Electron microscopic examinations of erythrocytes in hemoglobinopathy (Hb Wien)]. Wien Z Inn Med 1972 0.75
60 [Determination of acid phosphatase isoenzymes in lymphocytes by means of disc electrophoresis]. Wien Z Inn Med 1973 0.75
61 [Value of clinical symptoms in ankylosing spondylitis]. Acta Med Austriaca 1984 0.75
62 [Polymyalgia rheumatica]. Fortschr Med 1987 0.75
63 [Mixed connective tissue disease. Clinical studies on a new group of collagenoses]. Z Rheumatol 1976 0.75
64 [Collagenolytic enzymes of the skin in chronic polyarthritis - transformations during D-penicillamin therapy]. Z Rheumatol 1981 0.75
65 Systemic lupus erythematosus and pulmonary hypertension. Z Rheumatol 1981 0.75
66 [Thyroid gland inhibition test in patients with endocrine ophthalmic diseases]. Wien Klin Wochenschr 1971 0.75
67 [Acetylcholine receptor antibody in D-penicillamine therapy]. Z Rheumatol 1986 0.75
68 Approach to a hospital-based application of a medical expert system. Med Inform (Lond) 1986 0.75
69 [Essential cryoglobulinemia with accompanying angioneurotic edema]. Acta Med Austriaca 1979 0.75
70 Influence of diftalone on tolbutamide test and i.v. glucose tolerance test. Int J Clin Pharmacol Biopharm 1976 0.75
71 Intracellular distribution of ibuprofen within monocytes. Arzneimittelforschung 1996 0.75
72 Is soluble CD44 variant isoform 5 useful as a predicting factor and a parameter for long term observation in rheumatoid arthritis? Ann Rheum Dis 2002 0.75
73 Levamisole in systemic lupus erythematosus. Arthritis Rheum 1977 0.75
74 [Cytochemical studies of a new hemoglobinopathy (hemoglobin Vienna)]. Wien Klin Wochenschr 1971 0.75
75 [Important side effects of non-steroidal antirheumatic agents]. Wien Med Wochenschr 1982 0.75
76 [Plant agglutin in induced lymphocyte transformation in chronic polyarthritis]. Wien Z Inn Med 1972 0.75
77 [The implementation of a computerized documentation system for the evaluation of spa therapy in patients with rheumatoid arthritis (author's transl)]. Wien Klin Wochenschr 1976 0.75
78 [Systemic manifestations in rheumatoid arthritis. A multivariate analysis of 122 patients (author's transl)]. Wien Klin Wochenschr Suppl 1977 0.75
79 [Effect of inpatient rehabilitation measures on patients with total hip endoprostheses--evaluation 15 months after operation]. Acta Med Austriaca 1996 0.75
80 [Diagnostic significance of trocar-joint biopsy. Follow-up studies after 2-7 years (proceedings)]. Z Rheumatol 1976 0.75
81 [Are antinuclear factors a contraindication for penicillamine treatment in patients with rheumatoid arthritis? (author's transl)]. Wien Klin Wochenschr 1978 0.75
82 [Peroxidase content of peripheral blood myeloid cells in hematological diseases (preliminary report)]. Wien Klin Wochenschr 1973 0.75
83 [Myleran lung in chronic myelosis]. Wien Z Inn Med 1973 0.75
84 [Therapy evaluation in rheumatology with an electronic data processing system]. Acta Med Austriaca 1976 0.75
85 [Cytochemical studies in megakaryocytes in hematologic diseases]. Folia Haematol Int Mag Klin Morphol Blutforsch 1975 0.75
86 [Medical expert and consultation systems: review and examples for their use]. Acta Med Austriaca 1987 0.75
87 [Case report of a patient with coexistent rheumatoid arthritis and ankylosing spondylitis]. Acta Med Austriaca 1979 0.75
88 [Comparison between early and late inpatient rehabilitation measures after implantation of total hip endoprostheses]. Rehabilitation (Stuttg) 1998 0.75
89 [Enzyme therapy of hemoblastosis with L-asparaginase]. Wien Z Inn Med 1969 0.75
90 [X-ray documentation of the anamnesis and physical data in patients with rheumatism within the scope of the medical information system WAMIS]. Acta Med Austriaca 1976 0.75
91 [Cytological and biochemical studies in a case of "di Guglielmo's syndrome"]. Folia Haematol Int Mag Klin Morphol Blutforsch 1975 0.75
92 [Measles antibodies in systemic lupus erythematosus (author's transl)]. Wien Klin Wochenschr 1978 0.75
93 Chest X-ray in collagen vascular diseases. A comparison of chest X-ray with bronchoalveolar lavage and transbronchial forceps biopsy. Respiration 1994 0.75
94 [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis]. Wien Klin Wochenschr Suppl 1984 0.75
95 [Enzyme content of peripheral blood leukocytes in pernicious anemia]. Folia Haematol Int Mag Klin Morphol Blutforsch 1973 0.75
96 [Baker cysts: an accompaniment of chronic diseases of the knee joint (author's transl)]. Rofo 1979 0.75
97 [Cytochemical studies on myeloma cells]. Folia Haematol Int Mag Klin Morphol Blutforsch 1973 0.75
98 [Systemic lupus erythematosus in twins (author's transl)]. Klin Padiatr 1978 0.75
99 Dermatoglyphics and systemic lupus erythematosus. Scand J Rheumatol 1981 0.75
100 [Diagnostic significance of trocar joint biopsy. Follow-up studies after 2--7 years]. Verh Dtsch Ges Rheumatol 1976 0.75
101 Diffuse idiopathic skeletal hyperostosis (DISH) of the spine: a risk factor after hip joint replacement? Br J Rheumatol 1990 0.75
102 [Indication and achievements of after-care examination in Hodgkin's disease. Report on nuclear medicine]. Fortschr Geb Rontgenstr Nuklearmed 1973 0.75
103 [Rehabilitation after lumbar intervertebral disk operation]. Acta Med Austriaca 1991 0.75
104 [Esterase defects in segmented granulocytes of leukemia]. Wien Z Inn Med 1971 0.75
105 [Letter: Clinical value of a commercial anti-nDNA-radioassay]. Dtsch Med Wochenschr 1976 0.75
106 [Assessment of inflammatory activity in chronic polyarthritis using radioactive isotopes]. Acta Med Austriaca Suppl 1977 0.75
107 [Pancreatic duct antibodies in Sjogren's syndrome and in chronic polyarthritis]. Verh Dtsch Ges Rheumatol 1978 0.75
108 Effect of levamisole on immunological parameters in patients with systemic lupus erythematosus. Scand J Rheumatol 1980 0.75
109 [Scintigraphic studies of bones in hemoblastoses]. Folia Haematol Int Mag Klin Morphol Blutforsch 1971 0.75
110 [Attempt of an exact analysis of strontium kinetics in hand deviations from the norm in PCP (Progressive Chronic Polyarthritis)]. Wien Z Inn Med 1973 0.75
111 [Late results of immunosuppressive therapy in rheumatoid arthtitis]. Verh Dtsch Ges Rheumatol 1972 0.75
112 [Preliminary results with a new non-steroidal antirheumatic drug (author's transl)]. Wien Klin Wochenschr 1975 0.75
113 Functional impairment of the sacroiliac joint after total hip replacement. Int Rehabil Med 1987 0.75
114 [Differential diagnostic value of nephelometrically determined protein fractions in the synovial fluid]. Z Rheumatol 1988 0.75
115 A short Larsen score is effective when evaluating radiographs in early rheumatoid arthritis. Acta Radiol 2006 0.75
116 [A non-steroidal antirheumatic agent (nabumetone): effectiveness and tolerance in short and long-term use]. Z Rheumatol 1983 0.75
117 [Clinical aspects of primary chronic polyarthritis (proceedings)]. Acta Med Austriaca Suppl 1976 0.75
118 [Whole-body distribution of 90-yttrium silicate after intra-articular therapeutic doses]. Radiobiol Radiother (Berl) 1979 0.75
119 [Alkaline phosphatase isoenzyme studies in progressive chronic polyarthritis]. Acta Med Austriaca 1974 0.75
120 [Serum concentration of beta-2-microglobulin, immunologic parameters and kidney function in lupus erythematosus]. Verh Dtsch Ges Rheumatol 1978 0.75
121 [Binding capacity of ibuprofen to muscle proteins]. Arzneimittelforschung 1994 0.75
122 [Chromosome studies before and after phenylbutazone infusion therapy]. Arzneimittelforschung 1979 0.75
123 HLA-DR1-positive patients suffering from rheumatoid arthritis are at high risk for developing mucocutaneous side effects upon gold therapy. Hum Immunol 1993 0.75
124 [Binding affinity of ibuprofen to collagen and other connective tissue components]. Arzneimittelforschung 1990 0.75
125 The use of questionnaires in the evaluation of the functional capacity in rheumatoid arthritis. Clin Rheumatol 1982 0.75
126 [Atypical course of toxoplasmosis in the adult]. Wien Z Inn Med 1973 0.75
127 [Osler's disease. Clinical results of 24 cases with special reference to liver findings]. Wien Z Inn Med 1972 0.75
128 [Familial myeloid leukaemias]. Wien Klin Wochenschr 1972 0.75
129 [Treatment of inoperable chondrosarcomas by radioactive sulphur (author's transl)]. Z Orthop Ihre Grenzgeb 1974 0.75
130 [Plasma cortisol levels and magnetic field therapy. Initial orientational study]. Med Welt 1982 0.75